Resumen de Sleep Aid Zolpidem Receives Revised Labeling

Diane S. Aschenbrenner

• * The labeling of zolpidem products (Ambien and others) has been revised to reflect the risk of next-morning cognitive impairment.

  * The recommended starting dose for women has been cut in half.

  * Patients taking the extended-release form of zolpidem shouldn't drive or engage in other activities that require complete mental alertness the morning after taking the sleep aid.